Nanomedicine Market: An Overview of Growth Factors and Future Prospects

Nanomedicine is essentially based on the medical application of nanotechnology in diagnosing, treating and/or prevention of diseases and infections. Nanotechnology-based drugs and treatments are applied for treating cardiovascular, neurological, and oncology diseases.

Nanomedicine is based on the utilization of knowledge pertaining to various nanoparticles, their medical usages, and their actions within the human body.

There still exists considerable scope for research in this domain, and scientists are currently engaged in further studying the treatment-worthiness of a number of nanoparticles such as fullerenes, dendrimers, drug conjugates, and nano crystals.
It is important to note that this area of medicine is still in its nascent stage mainly because it is a niche research area and it receives comparatively less research funding.

Future prospects of the nanomedicine market

A research report by Transparency Market Research, a U.S.-based market research company, projects that the nanomedicine market will be largely driven by partnerships between global research firms and leading industry institutes. These collaborations will play a crucial part in attracting more investments. The report states that the global market for nanomedicine is projected to witness a compounded annual growth rate (CAGR) of 12.3% between 2013 and 2019.

Oncology – a significant segment within the nanomedicine market

According to the market research report by Transparency Market Research, oncology was the largest application segment within the nanomedicine market with a total share of 38%. This is attributed to the large scale focus on developing drugs and treatments for cancer, and the fact that approved nanomedicine drugs also exist in the market.

However, cardiovascular applications of nanomedicine are regarded as being the fastest-growing segment within the nanomedicine market. A large number of people being affected by cardiovascular problems worldwide, and the availability of various devices catering to the needs of this patient segment are growth influencers in this market.

In addition, there has been a perceptible increase in support from various governments in bolstering research as well as product approvals within the nanomedicine segment; with this support likely to continue, the market for nanomedicine will continue to grow.

The need for research, investment and collaboration in the nanomedicine market

In the coming years, it is expected that further collaborations between academic institutes as well as research firms will provided a much-needed boost to the role of nanomedicine in chronic disease treatment.

Research and breakthroughs could lead to the emergence of new treatments and technologies, with more bioavailability.
Other factors such as a growing demand and acceptance of targeted drug delivery (especially where neurological disorders are concerned) has created a larger market for nanomedicine.

On the other hand, the prevalence of cardiovascular diseases is on the rise, and this trend asks for the introduction of drugs that possess higher efficiency and better therapeutic properties. This is yet another need that will propel demand for nanomedicine products.

Nanomedicine has already met with some success in oncology, and researchers and market players alike are buoyed by this success. Having realized the efficacy of nanomedicine in oncology, it is likely that the interest shown by market players to commercialize products in this segment will only rise.

It is projected that cardiovascular treatments are likely to emerge as the fastest growing market within the nanomedicine market between 2013 and 2019.

Increased collaboration between academic and research institutes will prove favorable for the nanomedicine market. A noteworthy example of this would be the collaboration between Elan Corporation Plc and Abbott Laboratories for the development of the Tricor drug. This collaboration was key to helping both players lower cost associated with research and development.

Looking forward, market analysts expect that breakthroughs in nanomedicine will be crucial to the development of treatments and products for diseases such as diabetes, cancer, neurological disorders, and cardiovascular diseases.

Advertisements
Self-Care Medical Devices Market Will Climb Above USD 16.9 Billion 2019

Self-Care Medical Devices Market Will Climb Above USD 16.9 Billion 2019

Self-Care Medical Devices Market (Blood Pressure Monitors, Heart Rate Monitors, Body Temperature Monitors, Blood Glucose Monitors, Pregnancy/Fertility Test Kits, Pedometers, Sleep Apnea Monitors and Nebulizers) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast (Value and Volume),2013 – 2019

Self care

Transparency Market Research is Published new Market Report Self-Care Medical Devices Market (Blood Pressure Monitors, Heart Rate Monitors, Body Temperature Monitors, Blood Glucose Monitors, Pregnancy/Fertility Test Kits, Pedometers, Sleep Apnea Monitors and Nebulizers) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast (Value and Volume),2013 – 2019″, The global self-care medical devices market was valued at USD 10.5billion in 2012 and is estimated to reach a market worth of USD 16.9 billion in 2019growing at a CAGR of 7.0% from 2013 to 2019.

Browse the full report with complete TOC at http://www.transparencymarketresearch.com/self-care-medical-devices.html

Healthcare is moving towards a precision based model of personal care. Self-care medical devices play a major role in providing personal care that will ultimately help the patients or individuals to manage episodic acute and chronic illnesses. Increasing patient population coupled with rising awareness of lifestyle disorders and rapid technological developments in medical devices have accentuated the growth of the self-care medical devices market globally. There is a rise in demand for self-medication and home-based treatment as more number of patients opt for diagnosis and treatment of specific diseases at their own comfort (home).Chronic conditions such as diabetes, asthma, blood pressure and other respiratory and cardiovascular diseases require continuous and regular lifelong monitoring. Rise in the number of people diagnosed with such diseases drives the demand for self-care medical devices. It is estimated that around 220 million people are affected by chronic diseases and approximately 85% of them require home healthcare services for monitoring on a regular basis. Thus, self-care medical devices are witnessing fast adoption by consumers, to measure parameters on a regular basis and also cut down medical costs and save time.

Self-care is a primary form of care for various chronic diseases namely diabetes, blood pressure, cardiovascular and others. It is referred to as an action that contributes in maintaining personal health with the use of various self-monitoring devices. The market for self-care medical devices is segmented as blood glucose monitors, blood pressure monitors, temperature monitors, Holter monitors, pregnancy/fertility test kits, sleep apnea monitors, nebulizers and pedometers. Self-care devices are used as primary care devices by patients, causing a shift in mode of treatment from hospital to home based healthcare. Factors such as rise in obese population, and increase in incidence rate of chronic diseases such as hypertension and diabetes are propelling the growth of the self-care medical devices market.

Browse the full report PDF with TOC : Self-Care Medical Devices Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast (Value and Volume),2013 – 2019

The North American region accounted for the largest market share of over 40% in 2012and is expected to dominate the market during the forecast period. Increasing incidence of cardiovascular and respiratory diseases are the major driving factors for the growth of self-care medical devices market in the North American region. Additionally, sedentary lifestyle, poor dietary habits, and development of new technologies prove to be a stimulus for market growth in the North American region. The Asia-Pacific region is expected to grow at the highest CAGR of 9.9% from 2013 to 2019, due to rise in geriatric population, changing lifestyles and rising stress levels. Also, a large patient pool suffering from diabetes, hypertension, stroke, respiratory and cardiovascular diseases, requiring continuous monitoring and care will also accentuate the uptake of self-care medical devices.

The self-care medical devices market is presently witnessing intense competition among the key market players. To gain a significant market share, manufacturers are introducing cost effective, portable, easy to use and innovative self-care medical products. The global self-care medical devices market includes major companies, namely Roche, Philips Healthcare, Omron Healthcare, GE Healthcare, Johnson and Johnson, Medtronic, Inc., ResMed Inc., among others.

The global self-care medical devices market is segmented as follows:

Self-Care Medical Devices Market, by Segments

  • Blood Glucose Monitors
  • Blood Pressure Monitors
  • Body Temperature Monitors
  • Heart Rate Monitors
  • Pregnancy/Fertility Test Kits
  • Sleep Apnea Monitors
  • Nebulizers
  • Pedometers

Self-Care Medical Devices Market, by Geography

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)

 

Blogs :

https://medicaldevicesnews.wordpress.com/

http://rahul28feb.blogspot.com/

http://heavyindustrynews.wordpress.com/

 

Elderly and Disabled Assistive Devices Market Will Climb Above USD 19.68 Billion in 2019

Transparency Market Research

Elderly and Disabled Assistive Devices Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019

Transparency Market Research is Published new Market Report “ Elderly and Disabled Assistive Devices Market (Medical Mobility Aids and Ambulatory Devices, Medical Furniture and Bathroom Safety Products, Hearing Aids and Vision & Reading Aids) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019,” the global elderly and disabled assistive devices market was valued atUSD 12.37 billion in 2012 and is expected to grow at a CAGR of 6.9% from 2013 to 2019, to reach an estimated value of USD 19.68 billion in 2019.

Browse the full report with Complte TOC athttp://www.transparencymarketresearch.com/elderly-disabled-assistive-devices.html

The devices that assist the elderly and disabled population patients in their day-to-day activities such as movement, listening and reading are termed as elderly and disabled assistive devices. These devices are both simple and complex in design. Devices such as wheelchairs, cranes, crutches and scooters are simple in design, while hearing aids, reading machines and transfer lifts represent design complexity. The market for these devices can be broadly categorized into medical mobility aids and ambulatory devices, medical furniture and bathroom safety products, vision and reading aids, and hearing aids. The global market for elderly and disabled assistive devices is expected to record a CAGR of 6.9% during the forecast period of 2013 to 2019.

This growth is attributed to the increase in government support and initiatives to ensure availability of these devices for a large consumer population. For instance, the governments of various nations such the U.S., U.K. and Switzerland provide grants to disabled people for purchasing assistive devices, whereas, the Canadian government allows disabled persons to pay little or no tax. A rise in global geriatric and disabled population will also support the growth of this market. It is estimated that the global elderly population will grow to reach a count of around 2,000 million by 2050. The growth of this market may, however, be negatively affected due to high cost of products such as bone anchored hearing aids (BAHA) that cost around USD 10,000. Presently, very few medical insurers reimburse these assistive devices, which will also hinder the growth of this market.

Browse the full report PDF with TOC : Elderly and Disabled Assistive Devices Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019

The hearing aids market accounted for the largest share of the total market in 2012, in terms of revenue. This is due to a large number of people suffering from hearing impairments globally, and introduction of technologically advanced products such as cochlear implants and BAHA. However, the medical mobility aids and ambulatory devices market is expected to show the highest growth due to the rising geriatric population and increasing government support in the form of grants and subsidies for the purchase of mobility devices. The market for medical mobility aids and ambulatory devices is expected to grow at a CAGR of over 8% from 2013 to 2019.

Geographically, North America is expected to be the largest regional market since most of the major manufacturers of these devices are based in the U.S. In addition, high disposable incomes and a favorable reimbursement scenario will also support the growth of this market. The Asia-Pacificregion is expected to witness the highest growth at a CAGR of 8.1%, owing to the increasing government support and rise in geriatric population significantly.

The key players in the global elderly and disabled assistive devices market include Sonova Holding AG, William Demant Holding A/S, Invacare Corporation, Sunrise Medical LLC, GN ReSound Group, Ai Squared, Drive Medical Design and Manufacturing, and Starkey Hearing Technologies. The market is highly fragmented, with a few key players catering to different segments of the market. For instance, Sonova Holding and William Demant Holding lead the hearing aids segment, whereas, Invacare Corporation and Sunrise Medical LLC lead the medical mobility aids and ambulatory devices market segment.

The global elderly and disabled assistive devices market has been segmented as below:

Elderly and Disabled Assistive Devices Market, by Types

  • Medical Mobility Aids and Ambulatory Devices
    • Wheelchairs
    • Mobility Scooters
    • Cranes and Crutches
    • Walkers and Rollators
    • Transfer Lifts
    • Door Openers
    • Others (Cushions, Pillow and Back Support)
  • Medical Furniture and Bathroom Safety Products
    • Medical Beds
    • Commodes & Showers Chairs
    • Ostomy Products
    • Bars and Railings
    • Others (Bath lifts and Pool Lifts)
  • Hearing Aids
    • Receiver-in-the-Ear (RITE) Aids
    • Behind-the-Ear (BTE) Aids
    • In-the-Ear (ITE) Aids
    • Canal Hearing Aids
    • Bone Anchored Hearing Aids (BAHA)
    • Cochlear Implants
  • Vision and Reading Aids
    • Video Magnifiers
    • Braille Translators
    • Reading Machines
    • Others (Books and Kitchen Appliances)

Elderly and Disabled Assistive Devices Market, by Geography

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)

 

Blogs :

http://rahul28feb86.wordpress.com/

http://globalmarketresearchreports.quora.com/

http://rahul28feb.blogspot.co.uk

Implantable Drug Delivery Devices Market is Expected to Reach USD 21.1 Billion Globally in 2018: Transparency Market Research

Implantable Drug Delivery Devices Market is Expected to Reach USD 21.1 Billion Globally in 2018: Transparency Market Research

Transparency Market Research

Market Research Reports : Transparency Market Research published new market report “Implantable Drug Delivery Devices (Contraceptives, Drug Infusion Pumps, Intraocular Implants, Drug Eluting, Bio-absorbable Stents, Biodegradable) Market- Global Industry Analysis, Size, Share, Trends and Forecast, 2012 – 2018,” in 2011, the global market for implantable drug delivery devices was calculated at USD 11.6 billion and is expected to grow at a CAGR of 8.8% from 2012 to 2018, to reach an estimated value of USD 21.1 billion in 2018.

Browse the full report at http://www.transparencymarketresearch.com/implantable-drug-delivery-devices.html

A growing prevalence of target disease segments such as prostate cancer, diabetic retinopathy, chronic pain causing diseases, cardiovascular diseases, colorectal cancer, a rising global prevalence of unwanted pregnancies and a rapidly aging global population are some of the most impact rendering drivers for the global implantable drug delivery devices market. Some of the other drivers for the market include government and NGO initiatives undertaken to promote contraceptive drug delivery implants, rising number of interventional cardiologists and the rising demand for minimally invasive surgeries. Introduction of biodegradable implantable drug delivery technologies and new products such as MicroChips catering to disease segments such as osteoporosis will serve the market as future growth opportunities.

The market for implantable drug delivery devices in cardiovascular applications held majority of the market share in 2011 and owing to the introduction of bio-absorbable stents expected in 2014, its market share is likely to witness further increase by 2018. The biodegradable drug delivery implant technology will grow at a faster CAGR in comparison to the non-biodegradable drug delivery implant technology due to the fact that they do not involve re-surgeries for device removal and eliminates side effects induced by the prolonged presence of the device in the body.

The North American implantable drug delivery devices market held majority of the market share in 2011. However, its market share is expected to drop by 2018 owing to the accelerated market growth in the Asian regions induced by the economic development of emerging nations with high unmet medical needs such as India and China.

Browse PDF : Implantable Drug Delivery Devices Market – Global Industry Analysis, Size, Share, Trends And Forecast, 2012 – 2018

Merck held a majority of the market share in the global contraceptive drug delivery implants market due to the high adoption rate of its implants namely NuvaRing, Implanon and Implanon Nxt. Merck is closely followed by Bayer HealthCare with its widely used hormonal IUD Mirena and the launch of a new hormonal IUD Skyla in the U.S. and Jaydess in Europe in 2013.

The global implantable drug delivery devices market is segmented into the following categories:

Implantable Drug Delivery Devices Market by Product Types

    • Implantable coronary drug eluting stents
    • Implantable bio-absorbable stents
    • Implantable contraceptive drug delivery devices
    • Implantable intraocular drug delivery devices
    • Implantable brachytherapy seeds
    • Implantable drug infusion pumps

Implantable Drug Delivery Devices Market by Technology

    • Biodegradable implantable drug delivery device technology
    • Non-biodegradable implantable drug delivery device technology

Implantable Drug Delivery Devices Market by Applications

    • Ophthalmology
    • Cardiovascular
    • Birth control/contraception
    • Oncology
    • Other (diabetes, chronic pain causing diseases)

Implantable Drug Delivery Devices Market by Geography

    • North America
    • Europe
    • Asia
    • Rest of the world (RoW)

Blogs :

https://medicaldevicesnews.wordpress.com/

http://medicalcaremarketnews.wordpress.com/

http://rahul28febblog.wordpress.com/

 

About Us

TransparencyMarket Researchis a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact US :

Sheela AK

90 Sate Street, Suite 700 Albany, NY 12207

Tel: +1-518-618-1030 USA – Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com